TLR2 and myeloid sarcoma: Experimental administration of defined bacterial ligands of TLR2, or the Gram-positive bacterium Streptococcus pneumoniae, increases clinical score in the murine EAE model of MS in a manner dependent on TLR2 (35, 36).